These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1839505)

  • 1. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
    Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA
    Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein.
    Carter DB; Deibel MR; Dunn CJ; Tomich CS; Laborde AL; Slightom JL; Berger AE; Bienkowski MJ; Sun FF; McEwan RN
    Nature; 1990 Apr; 344(6267):633-8. PubMed ID: 2139180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
    Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure.
    Goto F; Goto K; Miyata T; Ohkawara S; Takao T; Mori S; Furukawa S; Maeda T; Iwanaga S; Shimonishi Y
    Immunology; 1992 Oct; 77(2):235-44. PubMed ID: 1427977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes. Involvement of serine/threonine phosphatases in differential regulation.
    Vey E; Dayer JM; Burger D
    Cytokine; 1997 Jul; 9(7):480-7. PubMed ID: 9237810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gamma receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1 beta in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus.
    Marsh CB; Pope HA; Wewers MD
    J Immunol; 1994 May; 152(9):4604-11. PubMed ID: 8157973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and secretion of interleukin 1 receptor antagonist in monocytes and keratinocytes.
    Corradi A; Bajetto A; Cozzolino F; Rubartelli A
    Cytotechnology; 1993; 11 Suppl 1():S50-2. PubMed ID: 7763757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
    Arend WP; Joslin FG; Thompson RC; Hannum CH
    J Immunol; 1989 Sep; 143(6):1851-8. PubMed ID: 2528582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urine inhibitor of interleukin 1 activity that blocks ligand binding.
    Seckinger P; Lowenthal JW; Williamson K; Dayer JM; MacDonald HR
    J Immunol; 1987 Sep; 139(5):1546-9. PubMed ID: 2957429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells.
    Roux-Lombard P; Modoux C; Vischer T; Grassi J; Dayer JM
    J Rheumatol; 1992 Apr; 19(4):517-23. PubMed ID: 1593570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
    Burger D; Chicheportiche R; Giri JG; Dayer JM
    J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases.
    Déage V; Burger D; Dayer JM
    Eur Cytokine Netw; 1998 Dec; 9(4):663-8. PubMed ID: 9889411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.
    Mazzei GJ; Seckinger PL; Dayer JM; Shaw AR
    Eur J Immunol; 1990 Mar; 20(3):683-9. PubMed ID: 2138562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.
    Krzesicki RF; Hatfield CA; Bienkowski MJ; McGuire JC; Winterrowd GE; Chapman DL; Berger AE; McEwan RN; Carter DB; Chosay JG
    J Immunol; 1993 May; 150(9):4008-18. PubMed ID: 8473746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.